Αρχειοθήκη ιστολογίου

Τρίτη 21 Νοεμβρίου 2017

Determination of an optimal response cut-off able to predict progression-free survival in patients with well-differentiated advanced pancreatic neuroendocrine tumours treated with sunitinib: an alternative to the current RECIST-defined response



from #MedicinebyAlexandrosSfakianakis via xlomafota13 on Inoreader http://ift.tt/2jOkLm5
via IFTTT

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου